Aggregated price index with volume information
Summary:
- Chemicals: Specialty stocks down 1.0% on average while median return down 0.9% in a day
- Chemicals: Specialty stocks down 0.3% on average while median return down -0.3% in a week
- Chemicals: Specialty stocks down 4.3% on average while median return down 3.7% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $REX 28.4%, $FSI 22.8%, $NL 10.2%, $MEOH 7.6%, $GURE 6.3%
- 1M losers are : Losers for past month are $BAK -16.2%, $SES -18.5%, $CDXS -23.2%, $FF -29.9%, $AMTX -30.1%
- 1W winners are : Winners for past week are $GURE 12.6%, $AMTX 11.0%, $FSI 9.2%, $TROX 8.8%, $DQ 3.7%
- 1W losers are : Losers for past week are $NEU -8.5%, $RYAM -8.9%, $CDXC -11.1%, $LWLG -11.7%, $SSL -17.1%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 24.2%, for the past 3 months is 19.2%
In the past month for a 5 days rolling window, the highest corrrelation is 35.4%, the lowest correlation is 4.6%, the latest correlation is 12.0%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 87.7% between IOSP and KWR
The lowest correlation is -33.2% between CDXC and ECL
HOUSTON, April 25, 2024--Orion S.A. (NYSE: OEC), a specialty chemical company, today announced that its board of directors has declared an interim dividend to be paid in the third quarter of 2024 of $0.0207 per common share of the company, which is equivalent to the aggregate amount of approximately $1.25 million based on the number of common shares currently outstanding.
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.
ELV vs. AVTR: Which Stock Is the Better Value Option?
Aemetis (AMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.
Although the revenue and EPS for Dow Inc. (DOW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Evaluate the expected performance of Air Products and Chemicals (APD) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.